vs
FATE THERAPEUTICS INC（FATE）与T Stamp Inc（IDAI）财务数据对比。点击上方公司名可切换其他公司
FATE THERAPEUTICS INC的季度营收约是T Stamp Inc的1.5倍（$1.4M vs $908.9K），FATE THERAPEUTICS INC同比增速更快（-26.4% vs -39.3%），T Stamp Inc自由现金流更多（$2.0M vs $-112.0M），过去两年T Stamp Inc的营收复合增速更高（25.9% vs -15.7%）
因西斯治疗是1990年成立、总部位于亚利桑那州钱德勒的美国特色制药企业，核心产品Subsys是芬太尼的舌下含服液体制剂。芬太尼是一种见效极快的强效阿片类药物，用于缓解癌症患者爆发性疼痛，在美国，用于该适应症的芬太尼处方通常要求已有记录证明保守疗法无效。
T Stamp Inc（股票代码IDAI）研发并提供AI驱动的身份核验、信任评分与欺诈防护解决方案，服务覆盖金融科技、医疗健康、电商等领域，主要面向北美市场客户，助力企业安全验证用户身份、降低欺诈风险。
FATE vs IDAI — 直观对比
营收规模更大
FATE
是对方的1.5倍
$908.9K
营收增速更快
FATE
高出12.9%
-39.3%
自由现金流更多
IDAI
多$114.0M
$-112.0M
两年增速更快
IDAI
近两年复合增速
-15.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.4M | $908.9K |
| 净利润 | — | $-2.5M |
| 毛利率 | — | — |
| 营业利润率 | — | -224.9% |
| 净利率 | — | -279.9% |
| 营收同比 | -26.4% | -39.3% |
| 净利润同比 | 37.9% | 57.7% |
| 每股收益（稀释后） | — | $-0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FATEIDAI
| Q4 25 | $1.4M | $908.9K | ||
| Q3 25 | $1.7M | $872.5K | ||
| Q2 25 | $1.9M | $812.7K | ||
| Q1 25 | $1.6M | $545.5K | ||
| Q4 24 | $1.9M | $1.5M | ||
| Q3 24 | $3.1M | $511.1K | ||
| Q2 24 | $6.8M | $500.4K | ||
| Q1 24 | $1.9M | $573.7K |
净利润FATEIDAI
| Q4 25 | — | $-2.5M | ||
| Q3 25 | $-32.3M | $-1.9M | ||
| Q2 25 | $-34.1M | $-1.7M | ||
| Q1 25 | $-37.6M | $-2.2M | ||
| Q4 24 | — | $-6.0M | ||
| Q3 24 | $-47.7M | $-1.3M | ||
| Q2 24 | $-38.4M | $-2.6M | ||
| Q1 24 | $-48.0M | $-2.7M |
营业利润率FATEIDAI
| Q4 25 | — | -224.9% | ||
| Q3 25 | -1995.1% | -203.0% | ||
| Q2 25 | -1938.5% | -207.0% | ||
| Q1 25 | -2534.1% | -396.5% | ||
| Q4 24 | — | -81.2% | ||
| Q3 24 | -1703.9% | -523.7% | ||
| Q2 24 | -665.7% | -524.7% | ||
| Q1 24 | -2652.9% | -496.7% |
净利率FATEIDAI
| Q4 25 | — | -279.9% | ||
| Q3 25 | -1852.4% | -219.1% | ||
| Q2 25 | -1786.6% | -210.7% | ||
| Q1 25 | -2309.5% | -395.5% | ||
| Q4 24 | — | -401.5% | ||
| Q3 24 | -1551.0% | -245.7% | ||
| Q2 24 | -567.4% | -519.3% | ||
| Q1 24 | -2493.7% | -466.9% |
每股收益（稀释后）FATEIDAI
| Q4 25 | — | $-0.37 | ||
| Q3 25 | $-0.27 | $-0.72 | ||
| Q2 25 | $-0.29 | $-0.69 | ||
| Q1 25 | $-0.32 | $-0.89 | ||
| Q4 24 | — | $-3.14 | ||
| Q3 24 | $-0.40 | $-1.06 | ||
| Q2 24 | $-0.33 | $-3.19 | ||
| Q1 24 | $-0.47 | $-3.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $203.7M | $6.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $207.2M | $8.7M |
| 总资产 | $318.9M | $11.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FATEIDAI
| Q4 25 | $203.7M | $6.0M | ||
| Q3 25 | $215.4M | $5.4M | ||
| Q2 25 | $222.8M | $292.1K | ||
| Q1 25 | $240.4M | $1.1M | ||
| Q4 24 | $279.1M | $2.8M | ||
| Q3 24 | $296.9M | $598.0K | ||
| Q2 24 | $304.9M | $659.5K | ||
| Q1 24 | $121.3M | $816.7K |
股东权益FATEIDAI
| Q4 25 | $207.2M | $8.7M | ||
| Q3 25 | $234.1M | $6.1M | ||
| Q2 25 | $261.4M | $2.4M | ||
| Q1 25 | $288.4M | $4.1M | ||
| Q4 24 | $318.7M | $3.0M | ||
| Q3 24 | $362.3M | $5.4M | ||
| Q2 24 | $397.0M | $750.4K | ||
| Q1 24 | $426.1M | $1.4M |
总资产FATEIDAI
| Q4 25 | $318.9M | $11.2M | ||
| Q3 25 | $343.7M | $11.2M | ||
| Q2 25 | $371.6M | $5.7M | ||
| Q1 25 | $398.7M | $6.6M | ||
| Q4 24 | $440.7M | $8.6M | ||
| Q3 24 | $495.0M | $10.6M | ||
| Q2 24 | $528.8M | $5.2M | ||
| Q1 24 | $569.9M | $5.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-106.1M | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $-112.0M | $2.0M |
| 自由现金流率自由现金流/营收 | -8183.9% | 215.4% |
| 资本支出强度资本支出/营收 | 434.8% | 0.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-199.6M | $-5.7M |
8季度趋势，按日历期对齐
经营现金流FATEIDAI
| Q4 25 | $-106.1M | $2.0M | ||
| Q3 25 | $-24.4M | $-4.0M | ||
| Q2 25 | $-24.6M | $-2.1M | ||
| Q1 25 | $-33.8M | $-1.5M | ||
| Q4 24 | $-122.9M | $-2.7M | ||
| Q3 24 | $-29.4M | $-2.4M | ||
| Q2 24 | $-32.3M | $-1.6M | ||
| Q1 24 | $-33.4M | $-2.2M |
自由现金流FATEIDAI
| Q4 25 | $-112.0M | $2.0M | ||
| Q3 25 | $-26.6M | $-4.0M | ||
| Q2 25 | $-25.9M | $-2.1M | ||
| Q1 25 | $-35.0M | $-1.6M | ||
| Q4 24 | $-123.6M | $-2.7M | ||
| Q3 24 | $-29.9M | $-2.4M | ||
| Q2 24 | $-32.4M | $-1.6M | ||
| Q1 24 | $-33.4M | $-2.2M |
自由现金流率FATEIDAI
| Q4 25 | -8183.9% | 215.4% | ||
| Q3 25 | -1526.5% | -459.6% | ||
| Q2 25 | -1360.7% | -258.6% | ||
| Q1 25 | -2148.9% | -289.2% | ||
| Q4 24 | -6645.4% | -182.9% | ||
| Q3 24 | -973.1% | -475.4% | ||
| Q2 24 | -477.8% | -320.9% | ||
| Q1 24 | -1736.9% | -376.6% |
资本支出强度FATEIDAI
| Q4 25 | 434.8% | 0.8% | ||
| Q3 25 | 126.5% | 0.0% | ||
| Q2 25 | 71.4% | 0.2% | ||
| Q1 25 | 73.4% | 6.8% | ||
| Q4 24 | 39.2% | 0.1% | ||
| Q3 24 | 16.1% | 0.7% | ||
| Q2 24 | 0.8% | 1.3% | ||
| Q1 24 | 4.5% | 0.5% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
